2026-09-28

We Gave $2M To The AI Startup That Could Help The Most People | MOONSHOTS Live

Live awards show for the Build With Gemini XPRIZE, where five teams got 90 days from a blank page to build a revenue-generating company around a problem affecting 100,000+ people. Peter Diamandis frames the contest around a 'new social contract' that replaces college-then-job with purpose-plus-AI-plus-entrepreneurship. Judges Palmer Luckey, Cathie Wood, Logan Kilpatrick, and Mark Pincus answer a post-economic lightning round on what they'd build from zero, covering AI-native startups, the drug-discovery cost curve, data as AI's new bottleneck, and whether social media is salvageable. The show closes with $2M distributed across five finalist teams (Polyfork taking first for $500,000).

▶ Watch on YouTube

Topics

New social contract beyond college Economy ▶ 0:00

Diamandis opens by declaring the old do-well-in-school-get-a-degree-get-a-job path 'cooked' and proposes finding a purpose, then using AI and entrepreneurship to build a solution to a real problem.

Build With Gemini XPRIZE format AI ▶ 0:55

The XPRIZE challenged teams to pick a problem impacting 100,000 people and build a revenue-generating, profitable company from a clean sheet of paper in 90 days, in partnership with Google.

Post-economic roundtable: starting from zero Economy ▶ 5:31

Diamandis asks the four judges what they'd build if they lost their wealth and network and had to start over today.

Oxytocin doping to fight divorce Health ▶ 6:00

Palmer Luckey pitches a company using oxytocin (the mammal pair-bonding hormone) as marriage counseling to reduce divorce, framing it as safe, unregulated, and non-addictive.

AI-driven entrepreneurial explosion and hiring advice Economy ▶ 8:36

Cathie Wood argues entry-level job scarcity is a 'blessing in disguise' pushing young people toward starting their own AI-powered, employee-free companies.

AI cutting drug discovery cost and time Biotech ▶ 10:05

Wood says AI will cut new-drug development cost from about $2.4 billion to $600-700 million and shrink the timeline from 13 years to 8 or fewer, making healthcare the top field to enter with AI.

Data as AI's new bottleneck AI ▶ 11:08

Logan Kilpatrick says compute is de-risked and the real constraint on AI progress now is data, pointing to $10B+ data companies and a large share of the current YC batch building data businesses.

Reinventing social media with AI and agents AI ▶ 12:24

Mark Pincus says he'd rebuild the online social experience with AI and agents designed to minimize time spent in-app; Palmer Luckey counters that curated niche communities still deliver real value.

XPRIZE finalists and $2M prize ceremony Economy ▶ 14:45

Five finalist teams (MyFixem, Polyfork, Tizian Sierra, Dodo Prep, LaunchBridge) are introduced and awarded a combined $2M, with Polyfork taking first place at $500,000.

Predictions made

open Cathie Wood: Bitcoin will become the most important crypto asset as the world moves to agentic AI, with machines buying from other machines.

· due: unspecified · ▶ watch

“Bitcoin, we believe, is going to be the most important crypto asset, especially as we move to agentic AI.”

Your call:

open Cathie Wood: Rather than causing mass joblessness, AI will trigger an entrepreneurial explosion as laid-off and underemployed young people start their own AI-powered companies.

· due: unspecified · ▶ watch

“I think we're going to have an entrepreneurial explosion.”

Your call:

open Cathie Wood: AI will cut the cost of discovering and developing a new drug from $2.4 billion (including failures) to $600-700 million, and cut development time from 13 years to 8 years or fewer.

· due: unspecified · ▶ watch

“It's going to cut the cost... from $2.4 billion... to $600 to $700 million.”

Your call:

open Logan Kilpatrick: Today's roughly $10 billion data companies will become much, much more valuable very soon as the AI data ecosystem matures.

· due: unspecified · ▶ watch

“The best companies in this market are like $10 billion companies and will probably be much, much more valuable very, very soon.”

Your call:

Numbers that matter

XPRIZE threshold: a problem impacting 100,000 people Minimum scale requirement for the Build With Gemini XPRIZE challenge.
90 days from a clean sheet of paper to a revenue-generating company Contest build window for the five finalist teams.
New-grad unemployment: average 6 months, median 3 months Cathie Wood citing current entry-level hiring conditions.
90% of startups fail, 10% succeed Cathie Wood framing startup odds as still worth the bet.
Drug development cost drop: $2.4B to $600-700M; time drop: 13 years to 8 or fewer Cathie Wood's projection for AI's impact on drug discovery economics.
Leading AI data companies valued around $10 billion Logan Kilpatrick on the current state of the data ecosystem.
Fifth place prize: $100,000 Awarded to Dodo Prep.
Second place prize: $200,000 Awarded to Tizian Sierra.
First place prize: $500,000 Awarded to Polyfork.

Worth digging into

🕳️ Oxytocin as marriage counseling

Palmer Luckey pitched a real, buyable-today biotech intervention (oxytocin from Sigma-Aldrich) for pair bonding and divorce reduction, which is a concrete and testable claim.

🕳️ AI's effect on drug discovery economics

Cathie Wood's $2.4B-to-$600-700M and 13-year-to-8-year figures are specific and checkable, and would be a major rabbit hole for the Longevity/Biotech beat.

🕳️ The data-as-bottleneck thesis

Logan Kilpatrick's claim that compute is de-risked and data is now the constraint, with $10B+ data companies, points to a specific and fast-moving market worth tracking.

🕳️ Build With Gemini XPRIZE winners

Five real companies (MyFixem, Polyfork, Tizian Sierra, Dodo Prep, LaunchBridge) were built from zero in 90 days and funded live; worth tracking whether they survive and what they actually built.